Announcements
Open Access
Review
What is the Role of Coronary Physiology in the Management of Patients with Chronic Coronary Syndromes?
Alec Saunders1,2, Nick Curzen1,2,*
Show Less
1
Faculty of Medicine, University of Southampton, SO17 1BJ Southampton, UK
2
Cardiothoracic Care Group, University Hospital Southampton NHS Trust, SO16 6YD Southampton, UK
*Correspondence: nick.curzen@uhs.nhs.uk (Nick Curzen)
Academic Editor: Peter Kokkinos
Academic Editor: Peter Kokkinos
Rev. Cardiovasc. Med. 2022, 23(4), 145;
https://doi.org/10.31083/j.rcm2304145
Submitted: 3 January 2022 | Revised: 10 February 2022 | Accepted: 18 February 2022 | Published: 13 April 2022
(This article belongs to the Special Issue The contemporary role of coronary physiology in the evaluation and management of CAD)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract
The use of coronary physiology in patients with chronic coronary syndromes is highly variable, and the evidence base complex. Tests of coronary physiology have traditionally been invasive (e.g., fractional flow reserve), but novel non-invasive methods are now available which provide additional anatomical information (e.g., computed tomography-based fractional flow reserve and angiogram-derived physiology). This review summarises the evidence for and against the relative value of these tests for patients being investigated for chest pain that may represent chronic coronary syndromes, and for those triaged to percutaneous coronary intervention.
Keywords
coronary artery disease
coronary physiology
myocardial ischemia
coronary angiography
Figures
Fig. 1.